Seerpharma.com.au :: Pharmaceutical Consulting & Training :: Validation, GMP & Compliance UK | Singapore | Korea

   

 

 

Chronic Obstructive Pulmonary Disease: Treatment

Description: Chronic obstructive pulmonary disease is characterized by progressive airflow limitation that cannot be fully reversed, as well as abnormal inflammation due to chronic inhalation of particles or noxious gas. Symptoms rarely manifest in patients younger than age 40, though after onset, respiratory function declines precipitously over several years. This course will review COPD prognosis, staging, and available treatments.

COURSE OUTLINE
INTRODUCTION
1. Course Information
2. Interface Tour
3. Course Overview

PROGNOSIS
4. Objectives
5. Prognosis and Staging
6. Progress Check

PHARMACOLOGIC TREATMENT
7. Objectives
8. Bronchodilators: Beta-2 Agonists
9. Bronchodilators: Anticholinergics
10. Bronchodilators: Theophylline
11. Corticosteroids
12. Other Pharmacologic Agents
13. Oxygen Therapy
14. Progress Check

NON-PHARMACOLOGIC TREATMENT
15. Objectives
16. Prevention and Rehabilitation
17. Surgery
18. Progress Check

CONCLUSION
19. Summary


COURSE OBJECTIVES
Students completing this course should be able to:
  • Describe the three stages typical of COPD
  • Discuss end-stage mortality rates
  • Contrast emphysema, chronic bronchitis, and COPD
  • Describe the three-bronchodilator types and explain their mechanisms of action
  • Describe the role of steroids, mucoactive agents, and antibiotics in COPD treatment
  • Explain the role of oxygen therapies in the COPD treatment
  • Explain how adjunctive therapy like nutrition and physical rehabilitation can impact COPD
  • Describe the symptoms that indicate surgery, and name the types of COPD surgeries

 

   

SeerPharma has partnered with GeneEd to now distribute courses in Major Therapeutic Areas, Clinical Research, and Biotechnology & Genetics.

© SeerPharma Pty Ltd 2008 | Resources | Privacy Policy